Navigation Links
Port Valdez invertebrates stabilized 26 years after quake
Date:4/25/2011

It took 26 years for marine invertebrates living on the Port Valdez seafloor to stabilize after Alaska's Great Earthquake of 1964, according to a scientist at the University of Alaska Fairbanks.

"The earthquake, which measured 9.2 on the Richter scale, and the tsunami waves that followed, impacted every marine community in Prince William Sound," said Arny Blanchard, a research assistant professor at the UAF School of Fisheries and Ocean Sciences. Four decades of monitoring, including samples collected last year, have confirmed that the seafloor now resembles that of an undisturbed glacial fjord.

Blanchard's findings, along with those of Howard Feder, UAF professor emeritus, and Max Hoberg, UAF researcher, were published in the journal Marine Environmental Research. The findings shed light on how long it takes for seafloor ecosystems to recover after earthquakes.

The 1964 earthquake and resulting tsunami wreaked havoc on intertidal beaches and seafloor of Port Valdez, according to Feder, the leader of the biological component of the project from 1971 to 1990. Marine plants and animals on Port Valdez beaches were destroyed by the tsunami while the earthquake deposited massive amounts of sediment on the seafloor. This caused the whole community of bottom-dwelling marine invertebratessuch as sea worms, snails and clamsto change.

Some seafloor invertebrates usually found in glacial fjords like Port Valdez, such as the sea worms Terebellides stroemi and Galathowenia oculata, virtually disappeared. Other animals took advantage of the disturbance and colonized the area. One of those animals is a family of sea worms called Capitellidae. They became unusually dominant in the region for a few years. According to Blanchard, Capitellidae are known for being highly opportunistic and tolerant of disturbance.

The diversity and abundance of marine invertebrates in Port Valdez was highly variable from 1971 to 1989 compared to o
'/>"/>

Contact: Carin Stephens
cbstephens@alaska.edu
907-322-8730
University of Alaska Fairbanks
Source:Eurekalert

Page: 1 2

Related biology news :

1. Arctic governments and industry still unprepared for oil spills 20 years after Exxon Valdez
2. Bioavailable contaminants come from the Exxon Valdez oil catastrophe
3. Leading journal makes Exxon Valdez and other oil-related studies available free
4. Simple approach could clean up oil remaining from Exxon Valdez spill
5. Gulf oil spill similar to Exxon Valdez in initial social and mental impacts, study finds
6. Satellite imagery shows fragile Wilkins Ice Shelf destabilized
7. UV exposure has increased over the last 30 years, but stabilized since the mid-1990s
8. Anabolic steroids provide a competitive edge in power lifting years after doping has ended
9. Experiment demonstrates 110 years of sustainable agriculture
10. Singapore opens Fusionopolis, its second major R&D hub in 5 years
11. New book covers 16 years of MSU research in Yellowstone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... biologists, led by Clemson University associate professor Andrew S. ... will pave the way for novel anti-fouling paint for ... and industrial applications. , The team,s findings, published in ... larval stage of barnacles that attaches to a wide ... material that acts as an underwater heavy-duty adhesive. , ...
(Date:7/30/2014)... Portland Press Limited today announced an across-the-board increase ... , The 2013 InCites Journal Citation Reports (Thomson ... Biochemical Journal , Essays in Biochemistry ... Bioscience Reports all received increases in their ... Biochemical Society and published by Portland Press Limited. ...
(Date:7/30/2014)... A professor from Wayne State University,s College of ... National Science Foundation for the project, "Nanoparticle-directed synthesis ... National Science Foundation, nanotechnology is the creation and ... novel properties and functions. A major bottleneck in ... methods that connect different functional materials into one ...
Breaking Biology News(10 mins):Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2Across-the-board Impact Factor increases for Portland Press Limited 2NSF grant to Wayne State supports new concept for manufacturing nanoscale devices 2
... have created the first three-dimensional living tissue model, complete ... therapeutics to combat brain tumors. The 3-D model gives ... tissue cultures. The researchers created a glioma, or ... surrounds it. In a series of experiments, the team ...
... have succeeded in changing the genetic material of cancer ... in nanosurgery opens the door to new medical applications, ... A light scalpel to treat cancerous cells, The ... team uses a femtosecond laser (a laser with ultra-short ...
... Resolving the world,s major challenges whether climate change, ... scarcity requires a sweeping shift in our approach ... leading scientists told European policy makers today during ... and Societal Challenges for our Unstable Earth" (RESCUE). ...
Cached Biology News:Researchers make living model of brain tumor 2Europe needs a 'RESCUE' revolution 2Europe needs a 'RESCUE' revolution 3
(Date:7/30/2014)... , July 30, 2014  Orexigen Therapeutics, Inc. (Nasdaq: ... the Day 180 List of Outstanding Issues (LOI) from ... Human Use (CHMP) for the NB32 Marketing Authorization Application ... is an investigational drug candidate being evaluated for weight ... Day 120 time point were adequately addressed by the ...
(Date:7/30/2014)...  AtheroNova Inc. (OTCBB: AHRO), a biotech company ... to safely regress atherosclerotic plaque and improve lipid ... CardioNova, has accomplished first dosing of subjects for ... compound, AHRO-001.  This Phase 1b trial will be ... trial completed in February 2014, in which patients ...
(Date:7/30/2014)... July 30, 2014 Vala Sciences ... U.S. Environmental Protection Agency (EPA). This new contract ... toxicity models, including tests designed to assess the ... the formation of connections between neurons (synapses), which ... and synapse formation by environmental pollutants likely contributes ...
(Date:7/29/2014)... July 30, 2014 SoundConnect ... collaboration company, is proud to announce the strategic ... positions in their Boston, Charleston and Atlanta offices. ... the increased demand for hosted solutions, collaboration and ... and reduce cost. , SoundConnect was founded in ...
Breaking Biology Technology:Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3SoundConnect Organization and Culture is Evolving 2
... July 14 Bio-Optronics, Inc., a leader in healthcare workflow ... software solution that can simultaneously handle the most intricate scheduling ... staff schedules. , , Physician ... , Bio-Optronics President & CEO, ...
... , HALIFAX, NS, July 14 /PRNewswire/ - ImmunoVaccine ... entered into an agreement to exclusively license seven ... company. These proprietary antigens specifically target breast, ovarian ... antigens with its DepoVax(TM) delivery platform to develop ...
... , , TAMPA, Fla., July ... on the research and development of cancer immunotherapies, announces that the ... its dendritic cell therapy. , , ... I/II clinical trial testing the safety and efficacy of its immunotherapy ...
Cached Biology Technology:NEW Momentum(TM) Physician and Staff Scheduling Software for Imaging Centers, OB/GYN, and Other Specialty Practices Improves Productivity and Equity in Scheduling 2ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens 2Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial 2Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial 3